- M&A News
M&A News: Global M&A Deals Week of Feb 3 to 9, 2025
- IMAA
SHARE:
The Institute for Mergers, Acquisitions and Alliances (IMAA) provides a detailed weekly roundup of mergers and acquisitions news, highlighting the most significant global M&A deals. This essential update offers a snapshot of the latest movements and trends within the M&A market, showcasing the top transactions that stand out in the corporate world. Through this coverage, IMAA aims to furnish M&A professionals and enthusiasts alike with a comprehensive overview of the week’s M&A activities, helping them stay informed about the evolving landscape of global mergers and acquisitions.
The global mergers and acquisitions (M&A) market saw a surge in activity from February 3 to February 9, with 645 announced deals totaling USD 33.31 billion. Notably, 11 of these deals exceeded the USD 500 million mark, collectively accounting for USD 25.41 billion, which represents 76% of the total deal value for the week.
One of the standout transactions was Italy’s BPER Banca’s USD 4.5 billion acquisition of Banca Popolare di Sondrio, marking a significant move in Italy’s competitive banking sector. The deal is part of a broader trend of consolidation in the country’s crowded banking market. Through this acquisition, BPER aims to strengthen its position by expanding its branch network, customer base, and workforce, thereby enhancing its services and market reach. This move positions BPER for continued growth in a competitive Italian financial landscape.
This acquisition adds to a growing number of strategic moves in Italy’s banking sector. Last month, Banca Monte dei Paschi di Siena made a surprise USD 14 billion bid for Mediobanca, which was rejected. Meanwhile, UniCredit launched an offer for Banco BPM, which also rebuffed the bid, opting to pursue its own acquisition of asset manager Anima Holding.
Week-on-week data reveals a 28% increase in deal volume, from 505 to 645 deals. The deal value also saw a significant rise, with a 35% increase from USD 24.65 billion to USD 33.31 billion.
Top 5 M&A Deals for the Week
Here are the top 5 M&A Deals for the week of Feb 3 to 9, 2025 in detail:
Deal No. 1: BPER Banca SpA to Acquire Banca Popolare di Sondrio S.p.A for USD 4.50 Billion
Deal No. 2: Turn/River Management, L.P. to Acquire SolarWinds Corporation for USD 4.30 Billion
Deal No. 3: Bain Capital Private Equity, LP to Acquire Mitsubishi Tanabe Pharma Corporation for USD 3.30 Billion
Deal No. 4: Berkshire Partners LLC; Warburg Pincus LLC to Acquire Triumph Group, Inc. for USD 3.00 Billion
Deal No. 5: Meiji Yasuda Life Insurance Company to Acquire Legal & General America, Inc. for USD 2.30 Billion
Deal No. 1:
BPER Banca SpA to Acquire Banca Popolare di Sondrio S.p.A for USD 4.50 Billion
BPER Banca has initiated a EUR 4.3 billion (USD 4.5 billion) all-share takeover bid for Banca Popolare di Sondrio, aiming to expand its market presence and strengthen its competitive position in the Italian banking sector.
Based in Sondrio, Lombardy, Banca Popolare di Sondrio is a cooperative bank operating mainly in northern and central Italy, offering retail and corporate banking, asset management, and insurance services. As of 2024, it reported total assets of approximately EUR 54 billion. If completed, the acquisition would add nearly 400 branches, close to 4,000 employees, and over 900,000 customers to BPER Banca’s network.
The deal is expected to accelerate growth and enhance value creation by integrating two institutions with complementary business models and shared strategic priorities. The merged group would benefit from a broader customer base, an expanded geographic footprint, and operational synergies, driving long-term profitability. The transaction is projected to generate net profits exceeding EUR 2 billion by 2027, with an anticipated return on tangible equity of approximately 15%.
Pending regulatory approvals, the acquisition is anticipated to close in the second half of 2025.
Deal No. 2:
Turn/River Management, L.P. to Acquire SolarWinds Corporation for USD 4.30 Billion
Software-focused private equity firm Turn/River Capital has agreed to acquire SolarWinds Corporation in a USD 4.4 billion all-cash transaction, taking the company private.
SolarWinds is a well-established software provider specializing in solutions that help businesses manage their IT infrastructure, including networks, systems, and applications. Its diverse product portfolio includes observability tools, database management solutions, and IT service management platforms, catering to organizations of various sectors and sizes.
With Turn/River Capital’s expertise in scaling software companies and its focus on operational efficiency and customer success, the investment is expected to accelerate SolarWinds’ growth and drive further innovation. Upon completion of the deal, SolarWinds will retain its brand identity, but its common stock will be delisted from the New York Stock Exchange.
The acquisition is projected to close in the second quarter of 2025, subject to regulatory approvals and customary closing conditions. Goldman Sachs & Co. LLC acted as the lead financial advisor to SolarWinds, with Jefferies LLC also providing advisory services. J.P. Morgan, Barclays, Santander, and RBC Capital Markets served as financial advisors to Turn/River Capital.
Deal No. 3:
Bain Capital Private Equity, LP to Acquire Mitsubishi Tanabe Pharma Corporation for USD 3.30 Billion
Japanese pharmaceutical company Mitsubishi Tanabe Pharma is set to be acquired by U.S. private equity firm Bain Capital for USD 3.3 billion (JPY 510 billion), capitalizing on the significant growth potential of Japan’s healthcare sector.
Mitsubishi Tanabe Pharma specializes in therapeutic areas such as immunology, inflammation, vaccines, diabetes, and central nervous system and metabolic diseases. With a global workforce of over 5,000 employees, the company operates subsidiaries in Europe, the U.S., Korea, and other regions. As an independent entity, Mitsubishi Tanabe Pharma will continue its legacy of medical innovation, seeking new growth opportunities through business development, licensing, enhanced R&D productivity, commercialization, and strategic acquisitions.
Bain Capital’s extensive resources and healthcare expertise will provide Mitsubishi Tanabe Pharma with the support needed to accelerate growth. Japan’s life sciences sector presents ample opportunities, especially with government initiatives to streamline the development and approval of innovative medicines. Bain’s healthcare platform has a strong history of driving innovation and growth for pharmaceutical companies worldwide.
This acquisition enables Mitsubishi Tanabe Pharma to benefit from Bain’s clinical insights and support in creating a scalable platform, focusing on long-term drug development to address unmet medical needs and bring transformative treatments to patients in Japan and around the world.
The transaction is expected to be completed in the third quarter of 2025. Mitsubishi UFJ Morgan Stanley Securities and BofA Securities are serving as financial advisors to Bain Capital.
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation | Bain Capital
Bain to buy Japan’s Mitsubishi Tanabe Pharma for $3.4 billion | Reuters
Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal – The Japan Times
Bain throws down $3.3B to acquire Japan’s Mitsubishi Tanabe Pharma | Fierce Pharma
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn – Pharmaceutical Technology
Deal No. 4:
Berkshire Partners LLC; Warburg Pincus LLC to Acquire Triumph Group, Inc. for USD 3.00 Billion
Warburg Pincus and Berkshire Partners have entered into an agreement to acquire Triumph Group, a leading provider of aircraft systems and components, for USD 3 billion (USD 26 per share) in cash.
Triumph Group is a prominent aerospace manufacturer that designs, engineers, and produces a wide range of components and systems for the aerospace and defense sectors. Its diverse product lineup includes structural components, electrical systems, and landing gear, serving a global customer base that spans commercial aircraft manufacturers and defense contractors. The company is dedicated to innovation and operates across multiple segments, supporting both original equipment manufacturers (OEMs) and the aftermarket sector.
With Triumph’s strong engineering capabilities and the operational and financial backing of Warburg Pincus and Berkshire Partners, this acquisition positions the company for long-term growth and success. The deal underscores the rising demand for advanced aerospace solutions, with all involved parties set to benefit from expanding opportunities in the global aviation and defense markets.
The transaction is expected to finalize in the second half of 2025. Upon completion, Triumph Group will be delisted from the New York Stock Exchange. Goldman Sachs & Co. is acting as the exclusive financial advisor to Triumph, while Lazard is advising Warburg Pincus and Berkshire Partners.
Aero parts maker Triumph to go private in $3 billion deal | Reuters
Private equity firms to acquire Triumph for $3bn
American Axle to buy GKN automotive owner Dowlais in $1.4 billion deal | Reuters
American Axle to acquire Dowlais Group in $1.44B deal – USA Herald
American Axle & Manufacturing signs $1.44bn deal to acquire Dowlais
Deal No. 5:
Meiji Yasuda Life Insurance Company to Acquire Legal & General America, Inc. for USD 2.30 Billion
British multinational financial services firm Legal & General is divesting its US insurance business, Legal & General America, Inc., to Japan’s Meiji Yasuda Life Insurance for USD 2.3 billion. This sale is part of L&G’s broader strategy to refine its focus and streamline operations.
The agreement grants Meiji Yasuda full ownership of L&G’s US protection business and a 20% economic stake in L&G’s US Pension Risk Transfer (PRT) unit. L&G will retain an 80% interest in the existing and future PRT business through reinsurance arrangements with Meiji Yasuda. Additionally, Meiji Yasuda will acquire a 5% equity stake in L&G. Both companies plan to continue collaborating in the foreign private asset investments sector and explore new opportunities for mutual growth.
Meiji Yasuda anticipates that the acquisition will double its overseas insurance premiums to over USD 6.6 billion, with core profits rising to more than USD 660 million, up from USD 603 million before the transaction. The company views its international insurance business as a key driver of future growth, with a goal of reaching JPY 100 billion or more in base profit equivalents by 2027.
For L&G, the proceeds from the sale will help fund the US PRT reinsurance arrangement, with the remainder allocated according to the Group’s capital strategy.
The acquisition is expected to be finalized between the fourth quarter of 2025 and early 2026.
Legal & General to Sell U.S. Insurance Businesses in $2.3 Billion Deal – WSJ
Britain’s L&G sells US protection unit to Japanese insurer for $2.3 billion | Reuters
Meiji Yasuda plans acquisition of US-based Banner Life | Insurance Asia
Meiji Yasuda to acquire U.S. peer Banner Life – The Japan Times
Meiji Yasuda plans acquisition of US-based Banner Life | Insurance Asia
This concludes our M&A news coverage of the top global mergers and acquisitions deals for the week of Feb 3 to 9, 2025. For continuous and detailed insights into the evolving landscape of M&A news, we invite you to follow the Institute for Mergers, Acquisitions, and Alliances (IMAA).
Stay up to date with M&A news!
Subscribe to our newsletter
